Елтромбопаг

Eltrombopag Olamine is an oral medication used to support platelet production in adults and children with certain blood conditions. It belongs to the thrombopoietin receptor agonist class. This drug helps manage low platelet counts when other treatments are insufficient. Suitable for patients requiring chronic therapy for immune thrombocytopenia or hepatitis C-related thrombocytopenia.

Eltrombopag Olamine is primarily used to treat low platelet counts in conditions like immune thrombocytopenia (ITP) and hepatitis C-associated thrombocytopenia. It works by stimulating the bone marrow to produce more platelets, which helps prevent bleeding. Patients with chronic ITP or those undergoing interferon therapy for hepatitis C may benefit from this medication. It is not a first-line treatment but is prescribed when standard therapies are ineffective.

Common effects of Eltrombopag Olamine include mild nausea, headache, or fatigue, which are usually temporary. Some patients may experience changes in liver function tests, so regular monitoring is advised. The medication may also cause mild digestive discomfort or muscle aches. These effects vary by individual and often diminish over time.

Eltrombopag Olamine should be taken on an empty stomach, ideally one hour before or two hours after a meal. Avoid consuming calcium-rich foods or supplements within four hours of taking the dose. Patients with liver problems should use this medication with caution and under medical supervision. Keep the medication in a cool, dry place away from direct sunlight.

Eltrombopag Olamine may interact with medications that affect liver enzymes, such as certain antifungals or antibiotics. Avoid taking antacids or dairy products close to the dose, as they can reduce absorption. Grapefruit juice may also interfere with how the body processes the drug. Always inform your healthcare provider about all medications and supplements you are taking.